We are live on ! Find out more
ETRM

EnteroMedics Inc.
ETRM

Delisted

ETRM was delisted on the 20th of October, 2017.

26 hedge funds and large institutions have $1.08M invested in EnteroMedics Inc. in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 5

21% less funds holding

Funds holding: 3326 (-7)

39% less capital invested

Capital invested by funds: $1.75M → $1.08M (-$678K)

58% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 12

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $48K

Holders
26
Holders Change
-7
Holders Change %
-21.21%
% of All Funds
0.69%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
6
Reduced
5
Closed
12
Calls
Puts
$48K
Net Calls
-$48K
Net Calls Change
-$48K

ETRM Hedge Fund Activity: Q1 2016 in Review

26 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in EnteroMedics Inc. (ETRM) for Q1 2016, worth a combined $1.08M — down 39% from $1.75M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ETRM and 5 opened new positions — a net loss of 7 holders — while 5 trimmed existing stakes and 6 added.

The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $236K. The largest seller was Vanguard Group, cutting an estimated $58.6K.

  • 26 institutional investors held EnteroMedics Inc. (ETRM) as of Q1 2016, down from 33 in Q4 2015.
  • Funds reported $1.08M of EnteroMedics Inc. stock for Q1 2016, down 39% quarter-over-quarter.
  • 5 funds opened new EnteroMedics Inc. positions in Q1 2016 and 12 closed out, a net change of -7 holders.
  • The largest EnteroMedics Inc. buyer in Q1 2016 was Hudson Bay Capital Management, an estimated $236K added.
  • The largest EnteroMedics Inc. seller in Q1 2016 was Vanguard Group, an estimated $58.6K sold.

Based on aggregated 13F filings for Q1 2016.